Improved USER cloning for TALE assembly and its application to base editing

PLoS One. 2023 Aug 4;18(8):e0289509. doi: 10.1371/journal.pone.0289509. eCollection 2023.

Abstract

Transcription activator-like effectors (TALEs) have been widely used for genome editing, transcriptional regulation, and locus-specific DNA imaging. However, TALEs are difficult to handle in routine laboratories because of their complexity and the considerable time consumed in TALE construction. Here, we described a simple and rapid TALE assembly method based on uracil-specific excision reagent (USER) cloning. Polymerase chain reaction was amplified with TALE trimer templates and deoxyuridine-containing primers. The products were treated with USER at 37°C for 30 min, followed by the treatment of T4 DNA Ligase at 16°C for 30 min. The TALE trimer unit could be rejoined hierarchically to form complete TALE expression vectors with high efficiency. This method was adopted to construct TALE-deaminases, which were used in combination with Cas9 nickases to generate efficient C-to-T or A-to-G base editing while eliminating predictable DNA off-target effects. This improved USER assembly is a simple, rapid, and laboratory-friendly TALE construction technique that will be valuable for DNA targeting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cloning, Molecular
  • DNA / genetics
  • DNA / metabolism
  • DNA-Binding Proteins* / genetics
  • Gene Editing*
  • Gene Expression Regulation
  • Transcription Activator-Like Effectors / genetics

Substances

  • DNA-Binding Proteins
  • Transcription Activator-Like Effectors
  • DNA

Grants and funding

This work was supported by National Key Research and Development Program of China Stem Cell and Translational Research (2022YFA1105403), the Natural Science Foundation of Guangdong Province (2023A1515011487), the National Natural Science Foundation of China (82001974), the Youth Innovation Project of Guangdong Province University (2022KQNCX095), and Guangdong Yiyang Healthcare Charity Foundation (JZ2022018).